ADAR1 Capital Management’s Verona Pharma VRNA Stock Holding History

ADAR1 Capital Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-51,450	Closed	-$5.49M	–	296
2025 Q3	$5.49M	Buy	51,450 +23,000	+81%	+$2.4M	0.52%	45
2025 Q2	$2.69M	Buy	28,450 +8,450	+42%	+$626K	0.41%	47
2025 Q1	$1.27M	Sell	20,000 -9,100	-31%	-$544K	0.24%	72
2024 Q4	$1.35M	Buy	29,100 +19,100	+191%	+$717K	0.27%	65
2024 Q3	$288K	Buy	+10,000	New	+$246K	0.05%	145

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

ADAR1 Capital Management's VRNA Position: Q4 2025 in Review

ADAR1 Capital Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 51,450 shares — an estimated $5.49M sold.

ADAR1 Capital Management first reported a position in VRNA in Q3 2024 and held it in 5 quarters. The position peaked at $5.49M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

ADAR1 Capital Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
ADAR1 Capital Management sold 51,450 Verona Pharma shares in Q4 2025, an estimated $5.49M.
ADAR1 Capital Management first reported a position in Verona Pharma in Q3 2024 and held it in 5 quarters.
ADAR1 Capital Management's Verona Pharma position peaked at $5.49M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on ADAR1 Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.